1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999; 341:1284–91.
Article
2. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behçet's disease. Yonsei Med J. 2007; 48:573–85.
Article
3. Choi HJ, Seo MR, Ryu HJ, Baek HJ. Cross-cultural adaptation and validation of the Behçet's Disease Current Activity Form in Korea. Korean J Intern Med. 2015; 30:714–8.
4. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999; 38:728–33.
5. Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, et al. Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol. 2014; 41:599–612.
Article
6. Forbess C, Swearningen C, Yazici Y. Behçet's syndrome activity score (BSAS): a new disease activity assessment tool, composed of patient derived measures only, is strongly correlated with the Behçet's disease current activity form (BDCAF). Arthritis Rheum. 2008; 58(Suppl 9):S854.
7. Houssien DA, Stucki G, Scott DL. A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology (Oxford). 1999; 38:48–52.
8. Pincus T, Sokka T. Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S1–9.
9. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990; 335:1078–80.
10. Chang HK, Kim SY. Survey and validation of the criteria for Behçet's disease recently used in Korea: a suggestion for modification of the International Study Group criteria. J Korean Med Sci. 2003; 18:88–92.
11. Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES. The Behçet's Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J. 2008; 49:698–704.
Article
12. Pincus T. Why should rheumatologists collect patient selfreport questionnaires in routine rheumatologic care? Rheum Dis Clin North Am. 1995; 21:271–319.
Article
13. Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, et al. Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome. Rheumatology (Oxford). 1999; 38:734–6.
14. Neves FS, Moraes JC, Kowalski SC, Goldenstein-Schainberg C, Lage LV, Gonçalves CR. Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol. 2007; 26:1263–7.
Article
15. Choi HJ, Seo MR, Ryu HJ, Baek HJ. Validation and reliability of a Behçet's Syndrome Activity Scale in Korea. Korean J Intern Med. 2016; 31:170–5.